On October 24th, 2017, Shanghai CelLoud Co., Ltd. (hereinafter referred to as "CelLoud") Signed the strategic cooperation agreementand with Thermo Fisher Scientific-Life technology co., Ltd. (hereinafter referred to as "Life"). The general manager of Life Baohua Li，Marketing Department’s Juan Li, CEO of CelLoud Duanyang Zhang and Marketing director Cheng Li, participated in the signing ceremony.
In this cooperation, both parties aimed to promote the marketing and application of the gene molecular detection kit in the field of clinic and health management, so as to jointly expand the overseas market.
“The sequencing market is huge, which has been applied to health, medical and industry, and it has been proved powerful on genetic disease, oncology, reproductive health, infection, disease control, and so on. In such a large market, we need a large amount of applications to develop, and this could not completed by one, ten, even hundreds of sequencing companies. CelLoud’s wishes were to use its own advantages in bioinformation analysis of cloud platform, large data and high performance computing, work hand in hand with other partners such as hospitals, sequencing companies, third party clinical testing institute, scientific research institute, etc., to reconstruct a “ collaborated”, “sharing” and “win-win” ecological industrial chain.” Duanyang Zhang said at the signing ceremony.
Mr. Zhang also emphasized: “Life is a joint venture between Thermo Fisher and Daan Gene. Sanger sequencing technology is mature technic in clinic, and has extensive experiences in the development and declaration of the kits. It is a great honor to be able to cooperate with Life. We both believe that this collaborate is just the beginning. In the future, we will not only cooperate in a deeper level in the analysis base on the cloud platform, but also we will exchange our agents for mutual benefits, deeply mining the market to better serve in the clinic”.
The general manager of Life Baohua Li said: “In the field of sequencing, the biggest challenge in clinical and scientific research is that how to find a better way to translate the sequencing data into valuable information, to guide clinical care. During this progress, bioinformatics and database are essential factors. The cooperation with CelLoud can effectively apply its advantages in powerful IT and bioinformatic capabilities to provide more conveniences in data mining and genetic data interpretations for Life. Since the beginning of the partnership in 2013, CelLoud platform has provided over 20,000 genetic test reports to patients for Life.”
Mr. Li also said: “Since Life's continuously growing over the past two years, more and more demands and products will occur. We hope to, and to provide better serve to patients in clinic by means of continuously cooperate with CelLoud.”
Life needs a sense of ritual, and our cooperation hopes to perpetuate this ritual. Wish the cooperation of CelLoud and Life can keep shining brilliant sparks.Let's meet the challenges and create good performances.... Back